Your browser doesn't support javascript.
loading
Nasal and paranasal sinus mucosal melanoma: Long-term survival outcomes and prognostic factors.
Abt, Nicholas B; Miller, Lauren E; Mokhtari, Tara E; Lin, Derrick T; Richmon, Jeremy D; Deschler, Daniel G; Varvares, Mark A; Puram, Sidharth V.
Afiliação
  • Abt NB; Department of Otolaryngology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.
  • Miller LE; Department of Otolaryngology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA. Electronic address: lauren_miller@meei.harvard.edu.
  • Mokhtari TE; Department of Otolaryngology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.
  • Lin DT; Department of Otolaryngology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.
  • Richmon JD; Department of Otolaryngology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.
  • Deschler DG; Department of Otolaryngology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.
  • Varvares MA; Department of Otolaryngology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.
  • Puram SV; Department of Otolaryngology, Washington University School of Medicine, St. Louis, MO, USA.
Am J Otolaryngol ; 42(6): 103070, 2021.
Article em En | MEDLINE | ID: mdl-33930681
OBJECTIVE: To determine prognostic factors and survival patterns for different treatment modalities for nasal cavity (NC) and paranasal sinus (PS) mucosal melanoma (MM). METHODS: Patients from 1973 to 2013 were analyzed using the Surveillance, Epidemiology, and End Results (SEER) database. Kaplan-Meier method and multivariable cox proportional hazard modeling were used for survival analyses. RESULTS: Of 928 cases of mucosal melanoma (NC = 632, PS = 302), increasing age (Hazard Ratio [HR]:1.05/year, p < 0.001), T4 tumors (HR: 1.81, p = 0.02), N1 status (HR: 6.61, p < 0.001), and PS disease (HR: 1.50, p < 0.001) were associated with worse survival. Median survival length was lower for PS versus NC (16 versus 26 months, p < 0.001). Surgery and surgery + radiation therapy (RT) improved survival over non-treatment or RT alone (p < 0.001). Adding RT to surgery did not yield a survival difference compared with surgery alone (p = 0.43). Five-year survival rates for surgery and surgery + RT were similar, at 27.7% and 25.1% (p = 0.43). CONCLUSION: Surgery increased survival significantly over RT alone. RT following surgical resection did not improve survival.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias dos Seios Paranasais / Neoplasias Nasais / Melanoma / Cavidade Nasal / Mucosa Nasal Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias dos Seios Paranasais / Neoplasias Nasais / Melanoma / Cavidade Nasal / Mucosa Nasal Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos